Buy CABGOLIN 0.5MG Cabergoline Tablets USP Online

Description: ABGOLIN 0.5MG Cabergoline Tablets USP are a medication used primarily to treat hyperprolactinemia (high levels of prolactin hormone) and related disorders. Each tablet contains 0.5 mg of cabergoline, a dopamine receptor agonist that works by reducing the secretion of prolactin from the pituitary gland. Indications: Treatment of hyperprolactinemia and its symptoms, such as infertility, irregular menstrual periods, and breast milk production in non-breastfeeding women. Management of prolactin-secreting adenomas (tumors of the pituitary gland). Dosage and Administration: The usual dosage for ABGOLIN 0.5MG Cabergoline Tablets USP is determined by a healthcare provider based on the patient’s condition and response to treatment. It is typically taken orally once or twice a week. Dosage adjustments may be necessary based on individual patient needs and tolerability. Contraindications: Hypersensitivity to cabergoline or any component of the formulation. Uncontrolled hypertension or significant cardiovascular disease. History of fibrotic disorders or cardiac valvulopathy. Warnings and Precautions: Regular monitoring of cardiac function, including echocardiography, is recommended due to the potential risk of cardiac valvulopathy. Use caution in patients with renal impairment as dosage adjustments may be necessary. Avoid use during pregnancy and lactation unless clearly indicated and under medical supervision. Adverse Reactions: Common adverse reactions may include nausea, headache, dizziness, and fatigue. Rare but serious adverse effects include psychiatric disorders, including hallucinations and psychotic disorders, and rare cases of fibrotic complications. Storage: Store ABGOLIN 0.5MG Cabergoline Tablets USP in a cool, dry place away from direct sunlight. Keep out of reach of children. Disclaimer: This product description is for informational purposes only and should not replace professional medical advice. Always consult a healthcare provider for diagnosis and treatment recommendations.